Because of donors like you, we’re able to take bold legal action. Join us in continuing the fight—donate here.
ICAN has acquired a Department of Defense (DOD) request for proposal related to its self-spreading vaccine program, DARPA INTERCEPT. In addition, Autonomous Therapeutics has published results of a successful test of its self-spreading vaccines in monkeys and is continuing its drive to develop “synthetic immune systems.”
Last year, ICAN made headlines when we uncovered the worrying new threat posed by the U.S. Government’s funding of studies on self-spreading vaccines. ICAN’s attorneys have recently uncovered more information on DARPA’s INTERCEPT Program, which funded research and development of TIPs (therapeutic interfering particles) that would act as “tiny Trojan horses” to carry engineered viruses that can spread from person to person. The INTERCEPT program even planned to develop computer models to predict how TIPs could spread “from an individual cell to an organism to an entire population.”
FOIA records obtained by ICAN reveal the details of a 2016 DOD request for proposal (the first step in the competitive bidding process for federal contracts), stating that the INTERCEPT Program aimed to develop a biological system for replicating “human-like conditions” for the study of “long-term evolutionary dynamics of fast mutating pathogens, diseases and emerging pandemics of interest to DOD.” This contract was eventually awarded to Autonomous Therapeutics, Inc.
ICAN previously reported on Ariel Weinberger and Leor Weinberger, the co-founders of Autonomous Therapeutics. Now, it appears their potentially dangerous technology is gaining momentum. Leor Weinberger published a study that tested TIPs engineered for HIV on rhesus monkeys, and he is moving forward with plans to inject TIPs into terminally ill humans with HIV. This raises grave health and ethical concerns because TIPs would become a permanent part of the patients’ DNA—and could possibly spread to people outside the clinical trial.
ICAN’s legal team continues to work to ensure these technologies will not be used to infect anyone without their consent. ICAN has sued the government for the federal grants and contracts funding Autonomous Therapeutics and has sent a FOIA request for all INTERCEPT program reports. We will keep you posted as we learn more about this concerning “technology.”
To support future legal actions like this, click here to donate!
